Chrome Extension
WeChat Mini Program
Use on ChatGLM

Ki67 assessment protocol as an integral biomarker for avoiding radiotherapy in the LUMINA breast cancer trial.

Histopathology(2023)

Cited 1|Views22
No score
Abstract
ClinicalTrials.gov number, NCT01791829.
More
Translated text
Key words
Ki67,LUMINA,biomarker,breast cancer,clinical trial,immunohistochemistry,radiotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined